Pain and Major Depressive Disorder
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of California, Los Angeles
- Study ID
- NCT04556890
- Status
- Recruiting
Conditions
- Chronic Pain
- Major Depressive Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Active rTMS/Active iTBS DFPLC/Sham Pain M1 — DEVICEActive rTMS treatment for depression (600 pulses of active intermittent theta burst (iTBS) administrated at 120% MT to the left DLPFC) and sham treatment for pain at M1
- Active rTMS/Active iTBS — DEVICEActive rTMS treatment for both, depression and pain (600 pulses of iTBS to left DLPFC followed by 600 iTBS + 1500 pulses of 10 Hz to M1
Study Details
This study will examine the effects of brain stimulation on pain symptoms associated with Major depressive disorder. This study will enroll 54 Subjects. Study subjects will be asked to complete surveys about their mood and well-being, 2 blood draws, 2 MRIs, 3 electroencephalograms, and receive 30 treatments of blinded transcranial magnetic stimulation. There is no control group as all subjects will receive some form of active treatment. Subjects are required to participate in 30-33 study visits and volunteer 40 hours of their time. Compensation for this study is $150 for completing all study activities.
Key Dates
- Start date
- Mar 1, 2023
- Status verified
- Sep 2025
- Primary completion
- Jun 30, 2027
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 54 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active rTMS/Active iTBS DFPLC/Sham Pain M1
- Experimental: Active rTMS/Active iTBS
Primary Outcome Measure
Percent change in depression scores [ Time Frame: Through study completion, an average of 6 weeks ]
Central Contacts
- Doan Ngo, BS310-825-7797
- Juliana Corlier, PhD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCLA Semel Institute | Los Angeles | California | 90024 | Andrew F. Leuchter, MD (SUB_INVESTIGATOR) Juliana Corlier, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
Related Studies
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- A Phase I/II Study of PDC-1421 for Treating Depression in Cancer PatientsPHASE1/PHASE2 · Not Yet Recruiting · BioLite, Inc. · Los Angeles, California
- Long-Term Real-World Outcomes Study on Patients Implanted With a NeurostimulatorRecruiting · Abbott Medical Devices · Phoenix, Arizona
- Closed-Loop Deep Brain Stimulation for Major DepressionRecruiting · Andrew Krystal · San Francisco, California